Ministry seeks domestic production of 10 drug raw materials by 2024

This has become important to make an effort in supplying pharmacy and medicine material independently because the quality of the next generation depends on children’s health, which depends on immunization.

Jakarta The Ministry of Health is aiming to produce 10 medicine raw materials (BBOs) that people consume the most within the country by the end of 2024, Vice Health Minister Dante Saksono Harbuwono has said.

“If in the beginning, we can only domestically produce four BBOs, then we aim to make it six this year. Then, by the end of 2024, 10 BBOs can be produced domestically,” he noted during the ‘Pharmacy Supply Industry Independence and Resilience National Forum’, observed from here on Monday.

Currently, there are six medicine raw materials that cannot yet be produced domestically: Cefixime, Amlodipine, Candesartan, Ceftriaxone, Bisoprolol, and Lansoprazole, he highlighted.

In addition to promoting research for producing the six BBOs, the government will also produce 10 vaccines and four antigens domestically, he informed.

These will include vaccines for Japanese Encephalitis (JE), Human Papillomavirus (HPV), Pneumococcal Conjugate Vaccine (PCV), and Rotavirus.

“This has become important to make an effort in supplying pharmacy and medicine material independently because the quality of the next generation depends on children’s health, which depends on immunization,” Harbuwono expounded.

In addition, the government will also develop phytopharmaca based on therapeutic area and raw materials availability, the vice minister informed.

To this end, the government will transform the health sector to bolster its resiliency, especially through a transformation of the pharmacy and health device sector, he said.

It is expected that this sector’s resiliency will not only be improved by the government through the state budget but also through private enterprises, he added.

“The source is no longer just the state budget, but the private sector should be involved. The question is how universities could also participate in transforming the health sector,” he remarked.

 

Source: Antara News